5 insiders reported 7 Form 4 transactions for Quoin Pharmaceuticals, Ltd. (QNRX) over the past 18 months (most recent 2026-09-01). Recent activity: Culverwell Anthony James (Director) Buy 6,146 shares, Carter Denise P. (Chief Operating Officer) Buy 20,490 shares, Myers Michael (Chief Executive Officer) Buy 20,490 shares, Lawlor Sally Bridget (Chief Financial Officer) Buy 10,244 shares, LANGER DENNIS (Director) Buy 34,534 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Culverwell Anthony James | Director | Buy | 6,146 | $29,992 |
| 2026-09-01 | Carter Denise P. | Chief Operating Officer | Buy | 20,490 | $99,991 |
| 2026-09-01 | Myers Michael | Chief Executive Officer | Buy | 20,490 | $99,991 |
| 2026-09-01 | Lawlor Sally Bridget | Chief Financial Officer | Buy | 10,244 | $49,991 |
| 2026-08-28 | LANGER DENNIS | Director | Buy | 34,534 | $177,850 |
| 2026-08-28 | Culverwell Anthony James | Director | Buy | 31,352 | $161,463 |
| 2025-10-15 | LANGER DENNIS | Director | Buy | 15,152 | $128,640 |
来源：SEC Form 4 申报文件 · 截至 2026-09-01